Global Hospital Acquired Infection Control Market Report and Forecast 2024-2032

Global Hospital Acquired Infection Control Market Outlook

The global hospital acquired infection control market size reached a value of around USD 27.29 million in 2023. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 4.5% to reach USD 40.56 million by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Increasing Need for Proper Disinfection to Augment the Global Hospital Acquired Infection Control Industry

Disinfectants are crucial components in any healthcare setting. Disinfectants reduce the risk of contamination from pathogenic micro-organisms in hospitals rooms, operation theatres, and washrooms, and ICUs, among others. Therefore, this segment has been witnessing a steady growth.

Over the forecast period, the anticipated increase in demand for disinfectant sprays owing to the ease of use and quickness of de-contamination achieved by sprays, is likely to lead to new and innovative product launches in the hospital acquired infection control market. The rapid increase in the development of chemical disinfectants based on alcohol, chlorine compounds, and formaldehyde, among others, is likely to augment the segment’s growth in the coming years. 

North America Leads with a Significant Market Share for Hospital Acquired Infection Control

The market in the North America region is being driven by the high healthcare expenditure and favourable policies of governments aimed towards augmenting the protection from pathogens and bacterial contaminants at healthcare units.

The increasing prevalence of chronic diseases across the United States and Canada are propelling the rates of hospitalisation, thereby, propelling the demand for hospital acquired infection control. In the span of the forecast period, the increase in research and development activities in the region, owing to the strong foothold of major market players are likely to be the crucial driving factors in the market. 

Market Segmentation

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Hospital acquired infections are the type of infections which have been acquired during a visit to the hospital. These types of infections have been cultivated by the environment of the hospital and tend to be challenging to manage. Hospital acquired infection control aims at monitoring and identifying potential threats to patients in order to reduce the risk of disease transmission. 

Based on product, the market can be segmented into:

• Sterilisation
  • Low Temperature Sterilisation Equipment
  • Radiation Sterilisation Equipment
  • Heat Sterilisation Equipment
  • Steam Sterilisation
  • Others

• Protective Barriers

• Endoscopic Reprocessor Systems

• Disinfection
  • Disinfectant
  • Disinfecting Equipment

By indication, the hospital acquired infection control market has been divided into:

• Bloodstream Infections

• Hospital Acquired Pneumonia

• Urinary Tract Infections

• Surgical Site Infections

• Gastrointestinal Infections

• Others

On the basis of end use, the market has been categorised into:

• Ambulatory Surgical and Diagnostic Centres

• ursing Homes and Maternity Centres

• Hospitals and Intensive Care Units

• Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Rising Prevalence of Hospital Acquired Contaminations to Bolster the Hospital Acquired Infection Control Industry

The increasing prevalence of hospital acquired infections is driving the hospital acquired infection control market growth. In addition to this, the increasing efforts by governments and healthcare authorities to ensure the safety of healthcare workers and patients is further boosting the demand for hospital de-contamination equipment. The growing use of high-the medical equipment across hospitals and ambulatory surgical centres is accelerating the growth of hospital acquired infection control.

Moreover, geriatric patients are extremely susceptible to diseases caused by hospital acquired pathogens. In this regard, the anticipated rise in hospitalisation of the geriatrics is likely to catapult the demand for technologically advanced sterilisation and disinfection techniques. 

During the forecast period, the expected increase in healthcare awareness and increasing emphasis on personal hygiene among both patients and hospital staff are anticipated to provide impetus to the market. Furthermore, some of the other driving factors of the market include the rising healthcare expenditure, growing population, and rising disposable income in the emerging economies. 

Key Players in the Global Market for Hospital Acquired Infection Control

The report gives a detailed analysis of the following key players in the global hospital acquired infection control market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• 3M Company

• Becton, Dickinson and Company

• STERIS plc

• Getinge AB

• Tuttnauer Ltd.

• Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

Key Highlights of the Report